Dose regimen optimization of cephalothin for surgical prophylaxis against Staphylococcus aureus and coagulase negative staphylococci in dogs by pharmacokinetic/pharmacodynamic modeling | Synapse
March 3, 2026
Dose regimen optimization of cephalothin for surgical prophylaxis against Staphylococcus aureus and coagulase negative staphylococci in dogs by pharmacokinetic/pharmacodynamic modeling
Key Points
Cephalothin dosage optimization significantly reduces the risk of infections from staphylococcus aureus and coagulase negative staphylococci.
Modeling shows that effective prophylaxis is achieved with the right pharmacokinetic and pharmacodynamic parameters.
Assessment through pharmacokinetic/pharmacodynamic modeling enhances understanding of drug behavior in canine patients.
Results imply more effective surgical prophylaxis against bacterial infections in veterinary practices may be achievable.